Expanded breadth of virus neutralization after immunization with a multiclade envelope HIV vaccine candidate
- PMID: 15837367
- DOI: 10.1016/j.vaccine.2005.01.099
Expanded breadth of virus neutralization after immunization with a multiclade envelope HIV vaccine candidate
Abstract
Although the V3 loop of the human immunodeficiency virus type 1 (HIV-1) envelope (Env) effectively elicits potent neutralizing antibody responses, the specificity of the antibody response is often restricted to T cell line adapted (TCLA) strains and a small subset of primary isolates, limiting its utility for an AIDS vaccine. In this study, we have compared Env immunogens with substituted V3 regions to combinations of strains from different clades and evaluated their ability to expand the breadth of the neutralizing antibody response. When the V3 region from HIV BaL was substituted for HIV HXB2, an effective neutralizing antibody response against several clade B primary isolates was elicited, but it remained restricted to neutralization of most clade B isolates. In an attempt to expand this response further, a linear epitope recognized by the broadly neutralizing 2F5 antibody was inserted into V3. A V3 2F5 epitope was identified that bound to 2F5 and elicited a potent 2F5 antibody response as an immunogen, but the antisera neutralized only a lab-adapted strain and not primary isolates. In contrast, combinations of Envs from clades A, B, and C, elicited neutralizing antibodies to a more diverse group of primary HIV-1 isolates. These studies suggest that combinations of Env immunogens, despite the limited reactivity of the V3 from each component, can be used to expand the breadth of the neutralizing antibody response.
Similar articles
-
Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins.J Virol. 2005 Jan;79(2):771-9. doi: 10.1128/JVI.79.2.771-779.2005. J Virol. 2005. PMID: 15613305 Free PMC article.
-
Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations.J Immunol. 1993 Jun 15;150(12):5647-65. J Immunol. 1993. PMID: 8515081
-
Comparison of HIV Type 1 ADA gp120 monomers versus gp140 trimers as immunogens for the induction of neutralizing antibodies.AIDS Res Hum Retroviruses. 2005 Jan;21(1):58-67. doi: 10.1089/aid.2005.21.58. AIDS Res Hum Retroviruses. 2005. PMID: 15665645
-
Improving on nature: focusing the immune response on the V3 loop.Hum Antibodies. 2005;14(3-4):69-72. Hum Antibodies. 2005. PMID: 16720976 Review.
-
Challenges for structure-based HIV vaccine design.Curr Opin HIV AIDS. 2009 Sep;4(5):431-40. doi: 10.1097/COH.0b013e32832e6184. Curr Opin HIV AIDS. 2009. PMID: 20048708 Review.
Cited by
-
Modulation of the immune response to the severe acute respiratory syndrome spike glycoprotein by gene-based and inactivated virus immunization.J Virol. 2005 Nov;79(22):13915-23. doi: 10.1128/JVI.79.22.13915-13923.2005. J Virol. 2005. PMID: 16254327 Free PMC article.
-
Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge.Vaccine. 2012 Feb 27;30(10):1830-40. doi: 10.1016/j.vaccine.2011.12.131. Epub 2012 Jan 9. Vaccine. 2012. PMID: 22234262 Free PMC article.
-
Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications.J Virol. 2007 Oct;81(19):10209-19. doi: 10.1128/JVI.00872-07. Epub 2007 Jul 18. J Virol. 2007. PMID: 17634242 Free PMC article. Review. No abstract available.
-
Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection.J Virol. 2006 Sep;80(17):8745-62. doi: 10.1128/JVI.00956-06. J Virol. 2006. PMID: 16912322 Free PMC article.
-
Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs.Vaccine. 2007 Feb 9;25(8):1398-408. doi: 10.1016/j.vaccine.2006.10.046. Epub 2006 Nov 7. Vaccine. 2007. PMID: 17113201 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous